Amikacin 250 mg Injection

Description Powerful Antibiotic Injection for Serious Bacterial Infections AMITRU-250 Injection is a high-quality antibiotic medicine containing Amikacin Sulphate Injection I.P. 250 mg. It is used for treating serious bacterial infections in different parts of the body. This injectable antibiotic is trusted by doctors and healthcare professionals because of its strong action against harmful bacteria. Manufactured and marketed by Coniak Lifesciences, AMITRU-250 is widely used in hospitals, nursing homes, clinics, and healthcare centers for fast and effective infection management. It is specially formulated for I.M. and I.V. use under medical supervision. What is AMITRU-250 Injection? AMITRU-250 Injection contains Amikacin Sulphate 250 mg, which belongs to the aminoglycoside group of antibiotics. It works by stopping the growth of bacteria and helping the body recover from severe infections. This injection is generally prescribed when infections become serious or when other antibiotics are not giving proper results. Doctors commonly use Amikacin injections in cases of respiratory infections, urinary tract infections, blood infections, post-surgical infections, and hospital-acquired bacterial infections. Composition Each vial contains: Amikacin 250 mg Methyl Paraben IP 0.18% w/v Propyl Paraben IP 0.02% w/v Dosage Form: Injection Route: For I.M./I.V. Use Only Pack Size: 2 ml Vial Key Uses of AMITRU-250 Injection AMITRU-250 Injection is widely used for treating: Respiratory tract infections Pneumonia and lung infections Urinary tract infections (UTI) Blood infections (Sepsis) Skin and soft tissue infections Bone and joint infections Post-operative bacterial infections Hospital-acquired infections Severe bacterial infections in hospitalized patients Doctors prefer Amikacin injections for serious infections because they provide fast antibacterial action and effective infection control. How AMITRU-250 Injection Works AMITRU-250 works by blocking bacterial protein production. Without protein synthesis, bacteria cannot grow or survive. This helps stop the infection from spreading inside the body. Amikacin is known for its broad-spectrum antibacterial activity and is especially useful in severe bacterial infections that require quick medical attention. Benefits of AMITRU-250 Injection Strong Antibiotic Action Provides effective control against serious bacterial infections. Fast Relief from Infection Symptoms Helps reduce fever, swelling, pain, and infection-related discomfort. Trusted by Doctors Widely prescribed in hospitals and clinics. Suitable for Severe Infections Used in moderate to serious bacterial infection management. Quality Assured Product Manufactured under strict pharmaceutical quality standards. Reliable Injectable Antibiotic Designed for quick and effective antibacterial response. Why Choose AMITRU-250 Injection? High-quality Amikacin formulation Effective antibacterial action Trusted injectable antibiotic range Strong market demand in the hospital segment Competitive pricing Reliable product supply Manufactured by a trusted pharma company Ideal for hospital and PCD pharma business Directions for Use Use only under medical supervision Administered through the IM or I.V. route Dosage depends on the patient’s condition and the doctor’s advice Complete the prescribed antibiotic course Avoid self-medication Storage Instructions Store in a cool and dry place Protect from direct sunlight Keep away from children Do not freeze Safety Information Use only as prescribed by the physician Inform your doctor about kidney problems or hearing issues before use Pregnant and breastfeeding women should use only after medical advice Regular monitoring may be required during long-term use Avoid skipping doses for better infection control AMITRU-250 Injection PCD Pharma Franchise Opportunity Coniak Lifesciences offers profitable PCD Pharma Franchise opportunities for AMITRU-250 Injection across India. The injectable antibiotic market is growing rapidly, making this product a strong business opportunity for pharma distributors and franchise partners. Benefits for Franchise Partners Monopoly rights Promotional support Visual aids and marketing materials Competitive pricing Timely product delivery High-demand injectable product range Strong support from Coniak Lifesciences AMITRU-250 Injection has excellent demand in hospitals, clinics, nursing homes, and healthcare institutions, helping franchise partners grow their pharma business successfully. Frequently Asked Questions What is AMITRU-250 Injection used for? AMITRU-250 Injection is used for treating serious bacterial infections such as pneumonia, urinary tract infections, blood infections, and skin infections. Is AMITRU-250 an antibiotic? Yes, it contains Amikacin Sulphate, which is an aminoglycoside antibiotic. How is AMITRU-250 Injection administered? It is administered through intravenous (I.V.) or intramuscular (I.M.) injection under medical supervision. Can this injection treat viral infections? No, AMITRU-250 works only against bacterial infections and not viral infections like flu or the common cold. Is AMITRU-250 suitable for hospital use? Yes, it is widely used in hospitals and healthcare centers for serious infection management. Can I get a PCD Pharma Franchise for this product? Yes, Coniak Lifesciences offers PCD Pharma Franchise opportunities for AMITRU-250 Injection across India. Why do doctors prescribe Amikacin Injection? Doctors prescribe Amikacin injections because of their strong antibacterial action and effectiveness against severe bacterial infections.